VEXAS syndrome: Favourable clinical and partial haematological responses to subcutaneous abatacept therapy with 30-month follow up

Kylan Pathmanathan, Elise Taylor, John Balendra, Andrew Lim, Graeme Carroll

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Rheumatology (Oxford, England)
DOIs	https://doi.org/10.1093/rheumatology/keac054
Publication status	E-pub ahead of print - 30 Jan 2022
Externally published	Yes

Access to Document

@article{4ee37b0003d443a0afdb2446c627999d,

title = "VEXAS syndrome: Favourable clinical and partial haematological responses to subcutaneous abatacept therapy with 30-month follow up",

author = "Kylan Pathmanathan and Elise Taylor and John Balendra and Andrew Lim and Graeme Carroll",

year = "2022",

month = jan,

day = "30",

doi = "10.1093/rheumatology/keac054",

language = "English",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - VEXAS syndrome

T2 - Favourable clinical and partial haematological responses to subcutaneous abatacept therapy with 30-month follow up

AU - Pathmanathan, Kylan

AU - Taylor, Elise

AU - Balendra, John

AU - Lim, Andrew

AU - Carroll, Graeme

PY - 2022/1/30

Y1 - 2022/1/30

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000760872500001

U2 - 10.1093/rheumatology/keac054

DO - 10.1093/rheumatology/keac054

M3 - Article

C2 - 35094047

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

SN - 1462-0324

ER -